Abstract
The Hippo tumor suppressor pathway, which is well conserved from Drosophila to humans, has emerged as the master regulator of organ size, as well as major cellular properties, such as cell proliferation, survival, stemness, and tissue homeostasis. The biological significance and deregulation of the Hippo pathway in tumorigenesis have received a surge of interest in the past decade. In the current review, we present the major discoveries that made substantial contributions to our understanding of the Hippo pathway and discuss how Hippo pathway components contribute to cellular signaling, physiology, and their potential implications in anticancer therapeutics.
| Original language | English |
|---|---|
| Pages (from-to) | 2303-2319 |
| Number of pages | 17 |
| Journal | Cellular and Molecular Life Sciences |
| Volume | 75 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 2018 Jul 1 |
Bibliographical note
Funding Information:Acknowledgements We apologize to those colleagues, whose work has not been cited because of space limitations. This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant Number: HI17C1560), and the National Research Foundation of Korea (NRF) Grant funded by the Korea government (2017R1A4A1015328 and 2018R1C1B6004301), and funded by the Yonsei University Future-leading Research Initiative of 2017 (2017-22-0071) to H.W.P. In addition, S.H.M and S.Y.P were supported by the Brain Korea (BK21) PLUS Program.
Publisher Copyright:
© 2018, Springer International Publishing AG, part of Springer Nature.
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Cellular and Molecular Neuroscience
- Cell Biology
